PS-1145
|
I339440-50mg
|
≥98% |
431898-65-6 |
50mg
|
¥ 1814.9
|
现货 |
阿拉丁 |
PS-1145
|
I339440-25mg
|
≥98% |
431898-65-6 |
25mg
|
¥ 1047.9
|
现货 |
阿拉丁 |
PS-1145
|
I339440-100mg
|
≥98% |
431898-65-6 |
100mg
|
¥ 3084.9
|
现货 |
阿拉丁 |
三(4-溴苯基)胺
|
T107949-500g
|
≥98% |
4316-58-9 |
500g
|
¥ 1309.9
|
现货 |
阿拉丁 |
4-甲基邻苯二甲酸
|
M158252-5g
|
≥98% |
4316-23-8 |
5g
|
¥ 171.9
|
现货 |
阿拉丁 |
四氢黄莲碱
|
T274671-25mg
|
≥97% |
4312-32-7 |
25mg
|
¥ 2779.9
|
现货 |
阿拉丁 |
四氢黄莲碱
|
T274671-10mg
|
≥97% |
4312-32-7 |
10mg
|
¥ 1366.9
|
现货 |
阿拉丁 |
四氢黄莲碱
|
T274671-100mg
|
≥97% |
4312-32-7 |
100mg
|
¥ 7414.9
|
现货 |
阿拉丁 |
DPO-1,KV1.5和IKurcurrent的通道阻滞剂
|
D287466-5mg
|
Moligand™, ≥98% |
43077-30-1 |
5mg
|
¥ 925.9
|
现货 |
阿拉丁 |
DPO-1,KV1.5和IKurcurrent的通道阻滞剂
|
D287466-25mg
|
Moligand™, ≥98% |
43077-30-1 |
25mg
|
¥ 3206.9
|
现货 |
阿拉丁 |
DPO-1,KV1.5和IKurcurrent的通道阻滞剂
|
D287466-100mg
|
Moligand™, ≥98% |
43077-30-1 |
100mg
|
¥ 8212.9
|
现货 |
阿拉丁 |
1,3-BIS(3,4-二氯苯)脲
|
B170333-5g
|
≥98% |
4300-43-0 |
5g
|
¥ 1306.9
|
现货 |
阿拉丁 |
1,3-BIS(3,4-二氯苯)脲
|
B170333-25g
|
≥98% |
4300-43-0 |
25g
|
¥ 5344.9
|
现货 |
阿拉丁 |
1,3-BIS(3,4-二氯苯)脲
|
B170333-1g
|
≥98% |
4300-43-0 |
1g
|
¥ 482.9
|
现货 |
阿拉丁 |
1-BOC-3-甲氧基基氮杂环丁烷
|
B133708-25g
|
≥95% |
429669-07-8 |
25g
|
¥ 1946.9
|
现货 |
阿拉丁 |
Y16
|
Y413617-50mg
|
≥98% |
429653-73-6 |
50mg
|
¥ 3394.9
|
现货 |
阿拉丁 |
Y16
|
Y413617-1mg
|
≥98% |
429653-73-6 |
1mg
|
¥ 286.9
|
现货 |
阿拉丁 |
Y16
|
Y413617-10mg
|
≥98% |
429653-73-6 |
10mg
|
¥ 1078.9
|
现货 |
阿拉丁 |
Y16
|
Y413617-100mg
|
≥98% |
429653-73-6 |
100mg
|
¥ 5533.9
|
现货 |
阿拉丁 |
丹酰-L-亮氨酸环己基铵盐
|
D336312-25mg
|
≥98% |
42954-58-5 |
25mg
|
¥ 439.9
|
现货 |
阿拉丁 |
7-硝基-1,2,3,4-四氢异喹啉
|
N184506-25g
|
≥98% |
42923-79-5 |
25g
|
¥ 1470.9
|
现货 |
阿拉丁 |
14-脱氧-11,12-二氢穿心莲内酯
|
D334600-50mg
|
≥97% |
42895-58-9 |
50mg
|
¥ 6599.9
|
现货 |
阿拉丁 |
14-脱氧-11,12-二氢穿心莲内酯
|
D334600-25mg
|
≥97% |
42895-58-9 |
25mg
|
¥ 4633.9
|
现货 |
阿拉丁 |
14-脱氧-11,12-二氢穿心莲内酯
|
D334600-1mg
|
≥97% |
42895-58-9 |
1mg
|
¥ 556.9
|
现货 |
阿拉丁 |